Latest News

August 21, 2014
The second round of funding opportunities for the Technology Development Award from the University of California Center for Accelerated Innovation (UC CAI) has begun.
December 06, 2013
UC San Francisco’s Health eHeart Study – an ambitious technology-based cardiovascular research study – has garnered the support from the American Heart Association, the largest U.S. non-profit organization dedicated to reducing disability and deaths caused by cardiovascular disease and stroke.
November 12, 2013
UCSF faculty members will discuss their cutting-edge approaches to researching and delivering health care on at Dreamforce 2013’s “Unusual Thinkers” track.
October 01, 2013
UCSF researchers received six of 78 awards announced this week by the National Institutes of Health for innovative, high-risk, high-reward research.
May 09, 2013
Lowell High School football player Jacky Tang went through a barrage of medical tests at UCSF’s PlaySafe Cardiac Physicals, an interdisciplinary clinic designed to detect underlying medical abnormalities in young athletes and prevent sudden death.
March 19, 2013
A UCSF team has developed an ambitious online cardiovascular study using smartphones, with the goal of enrolling 1 million people from all over the world to improve heart health.
February 13, 2013
Giving chocolates on Valentine's Day is a billion-dollar business in the United States, but besides delighting our taste buds, dark chocolate actually has health benefits for the body, a UCSF cardiologist says.
February 11, 2013
A new study finds that hundreds of thousands of lives could be saved over 10 years if Americans reduced their sodium consumption to the levels recommended in federal guidelines.
January 31, 2013
Suitulaga “Sugi” Hunkin was suffering from heart failure by the age of 27, but he needed to lose 100 pounds to get in shape for transplant surgery at UCSF. To do that, he had to drastically change his lifestyle.
November 06, 2012
Hospitalized heart failure patients who received the drug, serelaxin, in a phase III clinical trial had fewer disease symptoms and as a group experienced 37 percent fewer deaths over six months, according to results of a new study.

Pages